期刊文献+

虚拟导航超声造影与常规超声造影定位检测肝局灶性病变的比较 被引量:17

Virtual navigation assisted contrast-enhanced ultrasound for focal liver lesion invisible in B-mode ultrasound
原文传递
导出
摘要 目的比较虚拟导航超声造影与常规超声造影检出二维超声显示困难肝局灶性病变的差异,探讨虚拟导航超声造影的应用价值。方法47个CT或MR提示但二维超声无法显示的肝局灶性病变,分别行虚拟导航超声造影和常规超声造影,对比两种造影方法的病灶检出率。结果常规超声造影和虚拟导航超声造影的病灶检出率分别为36.2%(17/47)和78.7%(37/47),后者明显高于前者(P〈0.01)。虚拟导航超声造影时图像融合成功率达100%,平均对位用时5min。当病灶位于肝边缘受肋骨或肺气影响、肝实质背景杂乱及病灶异常灌注时相较短或灌注差异不明显时,虚拟导航超声造影比常规超声造影更容易定位并检出病灶。结论虚拟导航超声造影可明显提高二维超声无法显示肝局灶性病变的造影检出率。 Objective To evaluate virtual navigation assisted contrast-enhanced ultrasound (VN- CEUS) by comparing VN-CEUS with routine CEUS in detecting focal liver lesion(FLL) invisible in B-mode ultrasound(BUS). Methods Forty-seven FLLs invisible in BUS were identified by CT/MR, and received VN-CEUS and routine CEUS respectively. Results The detection rate of VN-CEUS and routine CEUS were 78.7%(37/47) and 36. 2% (17/47), the former was much higher than the later (P 〈0.01). In all the cases,fusion of CT/MR with ultrasound was achieved successfully and average time for image fusion was 5 min. Compared with routine CEUS, VN-CEUS could more easily find FLLs shadowed by lung or ribs, FLLs in inhomogeneous liver background, and FLLs with brief or inapparent abnormal enhancement. Conclusions VN-CEUS can greatly improve the detection rate of FLL that was invisible in BUS.
出处 《中华超声影像学杂志》 CSCD 北大核心 2011年第5期390-392,共3页 Chinese Journal of Ultrasonography
基金 广东省科技计划项目(20098060700026和20108031600041) 2007年公益性行业科研专项经费(2007-2-10)
关键词 超声检查 微气泡 肝疾病 虚拟导航系统 Ultrasonography Microbubbles Liver diseases Virtual navigation system
  • 相关文献

参考文献10

  • 1Piscaglia F,Lencioni R,Sagrini E,et al.Characterization of focal liver lesions with contrast-enhanced ultrasound.Ultrasound Med Biol,2010,36:531-550.
  • 2Quaia E,Alaimo V,Baratella E,et al.Effect of observer experience in the differentiation between benign and malignant liver tumors after ultrasound contrast agent injection.J Ultrasound Med,2010,29:25-36.
  • 3Llovet JM,Fuster J,Bruix J,et al.The Barcelona approach:diagnosis,staging,and treatment of hepatocellular carcinoma.Liver Transpl,2004,10:S115-S120.
  • 4EFSUMB study Group.Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound(CEUS)-update 2008.Ultraschall Med,2008,29:28-44.
  • 5Quaia E,Calliada F,Bertolotto M,et al.Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent:diagnostic performance and confidence.Radiology,2004,232:420-430.
  • 6Crocetti L,Lencioni R,Debeni S,et al.Targeting liver lesions for radiofrequency ablation:an experimental feasibility study using a CT-US fusion imaging system.Invest Radiol,2008,43:33-39.
  • 7Hildebrand P,Martens V,Schweikard A,et al.Evaluation of an online navigation system for laparoscopic interventions in a perfused ex vivo artificial tumor model of the liver.HPB (Oxford),2007,9:190-194.
  • 8刘广健,吕明德,谢晓燕,周旭辉,徐辉雄,匡铭,徐作峰,郑艳玲,梁瑾瑜,黄蓓.实时虚拟导航系统引导消融治疗肝癌[J].中华超声影像学杂志,2006,15(10):758-760. 被引量:15
  • 9蒋天安,陈燕,敖建阳,翁慧芳,陈芬,赵齐羽.实时影像虚拟导航系统在肝癌微创治疗中的初步应用[J].中华超声影像学杂志,2009,18(9):768-771. 被引量:18
  • 10郭昌宇.超声与CT或MRI融合导航技术在介入诊疗中的临床应用[J].中华放射学杂志,2009,43(6):625-628. 被引量:16

二级参考文献23

  • 1刘广健,吕明德,谢晓燕,周旭辉,徐辉雄,匡铭,徐作峰,郑艳玲,梁瑾瑜,黄蓓.实时虚拟导航系统引导消融治疗肝癌[J].中华超声影像学杂志,2006,15(10):758-760. 被引量:15
  • 2Daly B,Templeton PA.Real-time CT fluoroscopy:evolution of an interventional tool.Radiology,1999,221:309-315.
  • 3Shibuya A,Nakazawa T,Saiqenji K,et al.Diaphragmatic hernia after radiofrequency ablation therapy for hepatocellular carcinoma.AJB,2006,186(5 Suppl):S241-S243.
  • 4Laesoke PF,Sampson LA,Brace CL,et al.Unintended thermal injuries from radiofrequency ablation:protection with 5% dextrose in water.A JR,2006,186(5 Suppi):S249-S254.
  • 5Bossi S,Di Stasi M,Buscarini E,et al.Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer.AIR,1996,167:759-768.
  • 6Goldberg SN,Gazelle GS,Solbiati L,et al.Ablation of liver tumors using percutaneous RF therapy.AJR,1998,170:1023-1028.
  • 7Kaufman JK,Lee MJ.Vascular & interventional radiology.Philadelphia:Moshy,2004:469-483,671-678.
  • 8Shiina S, Teratani T,Obi S, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology, 2005,129 : 122-130.
  • 9Aramaki M, Kawano K, Ohno T, et al. Microwave coagulation therapy for unresectable hepatocellular carcinoma. Hepatogastroenterology, 2004,51 : 1784-1787.
  • 10Iuchi H, Horiike N, Masumoto T, et al. Specially designed needleguided for intercostals puncture of hepatocellular carcinoma seen on computed tomography and not visualized on uhrasonography. Hepatol Res,2003,25:319-328.

共引文献37

同被引文献192

引证文献17

二级引证文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部